← Leaderboards
Shing Chang
Drugs For Neglected Diseases Initiative
$1,158,871
Attributed
$1,158,871
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $504.8K · FY2007–10$1M$750K$500K$250K$0
'07
'08
'09
'10
Funding mix
By agency
NIH$1,158,871 · 2
By mechanism
U01$931,433 · 1
R01$227,438 · 1
Top collaborators
No co-investigators on record.
Most similar at Drugs For Neglected Diseases Initiative
Same institution · by research overlap
- Robert Don$1,675,684
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsToxic EffectSafetyPre-ClinicalAdverse EffectsNational Institute Of Allergy And Infectious DiseaseNeglectProgramsInfectionLaboratoriesBinding (Molecular Function)BaseBiologicalBiological TestingAmphotericin B LiposomalLeadEpidemicAuthorization DocumentationChemical SynthesisAmphotericin BBangladeshEnsureFormulations, DrugComplex
Grant awards (3)
K777 for treatment of Chagas Disease: IND-enabling Studies and IND Submission$227,438
R01 · FY2010 · AI · contact PI
Development of a low cost formulation of amphotericin B$504,803
U01 · FY2008 · AI · contact PI
Development of a low cost formulation of amphotericin B$426,630
U01 · FY2007 · AI · contact PI